Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4894) 4894
Publication (380) 380
Book Review (190) 190
Book Chapter (23) 23
Book / eBook (12) 12
Dissertation (10) 10
Trade Publication Article (6) 6
Conference Proceeding (4) 4
Magazine Article (3) 3
Paper (3) 3
Data Set (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2967) 2967
index medicus (2601) 2601
pharmacology & pharmacy (1731) 1731
double-blind (1433) 1433
male (1383) 1383
female (1257) 1257
extended-release (1207) 1207
adult (981) 981
psychiatry (948) 948
middle aged (883) 883
efficacy (879) 879
treatment outcome (777) 777
delayed-action preparations (693) 693
clinical neurology (619) 619
aged (600) 600
placebo-controlled trial (572) 572
extended-release niacin (538) 538
extended release (525) 525
drug therapy (519) 519
safety (483) 483
medicine, general & internal (474) 474
analysis (467) 467
care and treatment (459) 459
pharmacokinetics (454) 454
double-blind method (449) 449
adolescent (417) 417
animals (389) 389
neurosciences (366) 366
randomized controlled trials as topic (328) 328
randomized controlled-trial (319) 319
quality-of-life (315) 315
young adult (312) 312
research (307) 307
medicine & public health (301) 301
clinical trials (297) 297
tolerability (291) 291
drugs (290) 290
dose-response relationship, drug (286) 286
risk factors (281) 281
pharmacotherapy (270) 270
dosage and administration (269) 269
drug administration schedule (260) 260
major depressive disorder (252) 252
tablets (250) 250
drug therapy, combination (249) 249
venlafaxine extended-release (247) 247
opioids (240) 240
child (238) 238
attention deficit disorder with hyperactivity - drug therapy (237) 237
urology & nephrology (237) 237
schizophrenia (236) 236
health aspects (235) 235
attention-deficit/hyperactivity disorder (234) 234
internal medicine (233) 233
children (232) 232
overactive bladder (231) 231
antidepressants (230) 230
time factors (230) 230
pain (229) 229
coronary-heart-disease (227) 227
placebo (227) 227
quality of life (226) 226
niacin (221) 221
open-label (220) 220
extended-release naltrexone (205) 205
article (204) 204
abridged index medicus (202) 202
adhd (197) 197
analgesics, opioid - administration & dosage (196) 196
cardiac & cardiovascular systems (193) 193
antidepressive agents - therapeutic use (192) 192
aged, 80 and over (190) 190
therapy (188) 188
depression (186) 186
drug delivery systems (185) 185
administration, oral (184) 184
medicine, research & experimental (183) 183
pharmacology/toxicology (183) 183
antipsychotic agents - therapeutic use (181) 181
pharmacology (175) 175
attention-deficit hyperactivity disorder (174) 174
urinary bladder, overactive - drug therapy (173) 173
cholesterol (172) 172
management (172) 172
secondary prevention (172) 172
atherosclerosis (171) 171
chemistry, pharmaceutical (168) 168
chronic pain (168) 168
depressive disorder, major - drug therapy (168) 168
deficit hyperactivity disorder (167) 167
usage (164) 164
clinical trials as topic (162) 162
prevention (162) 162
cross-over studies (161) 161
urinary incontinence (161) 161
extended-release tablets (160) 160
central nervous system stimulants - therapeutic use (159) 159
review (158) 158
analgesics, opioid - therapeutic use (157) 157
studies (156) 156
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4728) 4728
German (73) 73
Spanish (48) 48
French (28) 28
Turkish (14) 14
Russian (12) 12
Japanese (10) 10
Portuguese (8) 8
Korean (5) 5
Hungarian (4) 4
Italian (4) 4
Croatian (3) 3
Czech (3) 3
Polish (3) 3
Slovenian (3) 3
Chinese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Antagonist Treatment for Opioid Use Disorder Reply
by Wakeman, SE
AMERICAN JOURNAL OF MEDICINE, ISSN 0002-9343, 03/2017, Volume 130, Issue 3, pp. E119 - E119
MEDICINE, GENERAL & INTERNAL | EXTENDED-RELEASE NALTREXONE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: A cohort study
by Larochelle, Marc R and Bernson, Dana and Land, Thomas and Stopka, Thomas J and Wang, Na and Xuan, Ziming and Bagley, Sarah M and Liebschutz, Jane M and Walley, Alexander Y
Annals of Internal Medicine, ISSN 0003-4819, 08/2018, Volume 169, Issue 3, pp. 137 - 145
Background: Opioid overdose survivors have an increased risk for death. Whether use of medications for opioid use disorder (MOUD) after overdose is associated... 
UNITED-STATES | HEROIN OVERDOSE | MEDICINE, GENERAL & INTERNAL | INJECTION-DRUG USERS | BUPRENORPHINE | EXTENDED-RELEASE NALTREXONE | RANDOMIZED CLINICAL-TRIAL | FATAL OVERDOSE | IMPLANT-NALTREXONE | ORAL NALTREXONE | DEPENDENCE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Linking (Pyr)1apelin-13 pharmacokinetics to efficacy: Stabilization and measurement of a high clearance peptide in rodents
by Onorato, Joelle M and Xu, Carrie and Chen, Xue-Qing and Rose, Anne V and Generaux, Claudia and Lentz, Kimberley and Shipkova, Petia and Arthur, Susan and Hennan, James K and Haskell, Roy and Myers, Michael C and Lawrence, R. Michael and Finlay, Heather J and Basso, Michael and Bostwick, Jeffrey and Fernando, Gayani and Garcia, Ricardo and Hellings, Samuel and Hsu, Mei-Yin and Zhang, Rongan and Zhao, Lei and Gargalovic, Peter
Analytical Biochemistry, ISSN 0003-2697, 03/2019, Volume 568, pp. 41 - 50
Apelin, the endogenous ligand for the APJ receptor, has generated interest due to its beneficial effects on the cardiovascular system. Synthesized as a 77... 
Extended release | Beagle dog | Stabilization | Apelin-13 | Rodent | Mass spectrometry | ELISA
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Abuse-Deterrent Opioids (Reprinted from The Medical Letter on Drugs and Therapeutics vol 59, pg 95-96, 2017)
by Abramowicz, M and Zuccotti, G and Pflomm, JM
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, ISSN 0098-7484, 05/2018, Volume 319, Issue 19, pp. 2036 - 2036
MEDICINE, GENERAL & INTERNAL | OXYCONTIN | EXTENDED-RELEASE OXYCODONE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE
by Jellinger, Paul S and Handelsman, Yehuda and Rosenblit, Paul D and Bloomgarden, Zachary T and Fonseca, Vivian A and Garber, Alan J and Grunberger, George and Guerin, Chris K and Bell, David S H and Mechanick, Jeffrey I and Pessah-Pollack, Rachel and Wyne, Kathleen and Smith, Donald and Brinton, Eliot A and Fazio, Sergio and Davidson, Michael
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, ISSN 1530-891X, 04/2017, Volume 23, Issue Suppl 2, pp. 1 - 87
Objective: The development of these guidelines is mandated by the American Association of Clinical Endocrinologists (AACE) Board of Directors and American... 
C-REACTIVE PROTEIN | INTIMA-MEDIA THICKNESS | HIGH-DOSE ATORVASTATIN | ACTIVATING-FACTOR ACETYLHYDROLASE | HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA | ENDOCRINOLOGY & METABOLISM | TRIGLYCERIDE-RICH LIPOPROTEINS | DENSITY-LIPOPROTEIN-CHOLESTEROL | CORONARY-HEART-DISEASE | HEALTH-CARE PROFESSIONALS | EXTENDED-RELEASE NIACIN
Journal Article
Details down arrow
6. Full Text ESC/EAS Guidelines for the management of dyslipidaemias
by Reiner, eljko and Catapano, Alberico L and De Backer, Guy and Graham, Ian and Taskinen, Marja-Riitta and Wiklund, Olov and Agewall, Stefan and Alegria, Eduardo and Chapman, M. John and Durrington, Paul and Erdine, Serap and Halcox, Julian and Hobbs, Richard and Kjekshus, John and Filardi, Pasquale Perrone and Riccardi, Gabriele and Storey, Robert F and Wood, David and Bax, Jeroen and Vahanian, Alec and Auricchio, Angelo and Baumgartner, Helmut and Ceconi, Claudio and Dean, Veronica and Deaton, Christi and Fagard, Robert and Filippatos, Gerasimos and Funck-Brentano, Christian and Hasdai, David and Hoes, Arno and Kearney, Peter and Knuuti, Juhani and Kolh, Philippe and McDonagh, Theresa and Moulin, Cyril and Poldermans, Don and Popescu, Bogdan A and Reiner, eljko and Sechtem, Udo and Sirnes, Per Anton and Tendera, Michal and Torbicki, Adam and Vardas, Panos and Widimsky, Petr and Windecker, Stephan and Reviewers, Document and Funck-Brentano, Christian and Poldermans, Don and Berkenboom, Guy and De Graaf, Jacqueline and Descamps, Olivier and Gotcheva, Nina and Griffith, Kathryn and Guida, Guido Francesco and Gulec, Sadi and Henkin, Yaakov and Huber, Kurt and Kesaniemi, Y. Antero and Lekakis, John and Manolis, Athanasios J and Marques-Vidal, Pedro and Masana, Luis and McMurray, John and Mendes, Miguel and Pagava, Zurab and Pedersen, Terje and Prescott, Eva and Rato, Quitéria and Rosano, Giuseppe and Sans, Susana and Stalenhoef, Anton and Tokgozoglu, Lale and Viigimaa, Margus and Wittekoek, M. E and Zamorano, Jose Luis
European Heart Journal, ISSN 0195-668X, 7/2011, Volume 32, Issue 14, pp. 1769 - 1818
Dyslipidaemia | Triglycerides | Treatment | Cardiovascular diseases | Cholesterol | Guidelines | STATIN-TREATED PATIENTS | CARDIAC & CARDIOVASCULAR SYSTEMS | HIGH-DOSE ATORVASTATIN | LIPID-LOWERING THERAPY | HIV-INFECTED PATIENTS | DENSITY-LIPOPROTEIN CHOLESTEROL | POLYUNSATURATED FATTY-ACIDS | CORONARY-HEART-DISEASE | TYPE-2 DIABETES-MELLITUS | EXTENDED-RELEASE NIACIN | CARDIOVASCULAR RISK-FACTORS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text "Ghost tablet" husks excreted in feces in large bupropion XL overdose
by Overberg, Adam and Purpura, Andrea and Nanagas, Kristine
Clinical Toxicology, ISSN 1556-3650, 02/2019, Volume 57, Issue 2, pp. 141 - 142
Background: Extended-release medications are widely prescribed across the spectrum of medical specialties; however, there is heterogeneity in how they are... 
dosage forms | pharmaceuticals | CNS and psychological | bupropion | extended release | TOXICOLOGY
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text “Ghost tablet” husks excreted in feces in large bupropion XL overdose
by Overberg, Adam and Purpura, Andrea and Nanagas, Kristine
Clinical Toxicology, ISSN 1556-3650, 02/2019, Volume 57, Issue 2, pp. 141 - 142
dosage forms | pharmaceuticals | CNS and psychological | bupropion | extended release
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Cost-Effectiveness of Extended Release Naltrexone to Prevent Relapse Among Criminal-Justice-Involved Persons with a History of Opioid Use Disorder
by Murphy, Sean M and Polsky, Daniel and Lee, Joshua D and Friedmann, Peter D and Kinlock, Timothy W and Nunes, Edward V and Bonnie, Richard J and Gordon, Michael and Chen, Donna T and Boney, Tamara Y and O’Brien, Charles P
Addiction (Abingdon, England), ISSN 0965-2140, 8/2017, Volume 112, Issue 8, pp. 1440 - 1450
Extended release naltrexone | Cost effectiveness | Criminal justice populations
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Use of phentermine-topiramate extended release in combination with sleeve gastrectomy in patients with BMI 50 kg/m2 or more
by Ard, Jamy D and Beavers, Daniel P and Hale, Erica and Miller, Gary and McNatt, Stephen and Fernandez, Adolfo
Surgery for Obesity and Related Diseases, ISSN 1550-7289, 07/2019, Volume 15, Issue 7, pp. 1039 - 1043
Super obesity (body mass index [BMI] ≥50 kg/m ) treatment can be complicated and high risk. We studied whether the pre and postoperative use of phentermine and... 
Antiobesity medication | Phentermine/topiramate extended release | Super obesity | Sleeve gastrectomy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Overdose Prevention Through Medical Treatment of Opioid Use Disorders
by Volkow, Nora D and Wargo, Eric M
Annals of Internal Medicine, ISSN 0003-4819, 08/2018, Volume 169, Issue 3, pp. 190 - 192
CONTROLLED-TRIAL | RELAPSE | MEDICINE, GENERAL & INTERNAL | BUPRENORPHINE | EXTENDED-RELEASE NALTREXONE | DEPENDENCE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text LONG-ACTING FORMULATIONS FOR THE TREAMENT OF LATENT TUBERCULOSIS INFECTION: OPPORTUNITIES AND CHALLENGES
by Swindells, Susan and Siccardi, Marco and Barrett, Stephanie E and Olsen, David B and Grobler, Jay A and Podany, Anthony and Nuermberger, Eric and Kim, Peter and Barry, Clif and Owen, Andrew and Hazuda, Daria and Flexner, Charles
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, ISSN 1027-3719, 2/2018, Volume 22, Issue 2, pp. 125 - 132
Long-acting/extended release drug formulations have proved very successful in diverse areas of medicine including contraception, psychiatry, and most recently,... 
Tuberculosis | latent infection | long-acting | extended release
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text A Comparison of the Efficacy of Medications for Adult Attention-Deficit/Hyperactivity Disorder Using Meta-Analysis of Effect Sizes
by Faraone, SV and Glatt, SJ
JOURNAL OF CLINICAL PSYCHIATRY, ISSN 0160-6689, 06/2010, Volume 71, Issue 6, pp. 754 - 763
Objectives: Medications used to treat attention-deficit/hyperactivity disorder (ADHD) in adults have been well researched, but comparisons among drugs are... 
CONTROLLED CLINICAL-TRIAL | ADHD | DOUBLE-BLIND TRIAL | BUPROPION | PSYCHIATRY | DEFICIT HYPERACTIVITY DISORDER | METHYLPHENIDATE | PLACEBO-CONTROLLED TRIAL | LISDEXAMFETAMINE DIMESYLATE | PSYCHOLOGY, CLINICAL | EXTENDED-RELEASE | CHILDREN
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Injectable Pasty Biodegradable Polyesters Derived from Castor Oil and Hydroxyl-Acid Lactones
by Steinman, NY and Domb, AJ
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, ISSN 0022-3565, 09/2019, Volume 370, Issue 3, pp. 736 - 741
Pasty polymers offer a platform for injectable implants for drug delivery. A library of biodegradable pasty polymers was synthesized by bulk ring-opening... 
POLYMERS | BIOCOMPATIBILITY | PLGA | FILMS | PLA | DEGRADATION | PHARMACOLOGY & PHARMACY | IMPLANTS | EXTENDED-RELEASE | DELIVERY
Journal Article
Details down arrow
15. Full Text Water-insoluble polymers as binders for pellet drug layering: Effect on drug release and performance upon compression
by Zoubari, Gaith and Ali, Rebaz and Dashevskiy, Andriy
International Journal of Pharmaceutics, ISSN 0378-5173, 10/2019, Volume 569, p. 118520
The objective of this study was to investigate the applicability of water-insoluble polymers as binders for pellet drug layering to extend the drug release.... 
Extended release | Water-insoluble binder | Layering | Aqueous dispersion | Pellet compression | IPA:water solution
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Trends in Opioid Analgesic Abuse and Mortality in the United States
by Dart, Richard C and Surratt, Hilary L and Cicero, Theodore J and Parrino, Mark W and Severtson, S. Geoff and Bucher-Bartelson, Becki and Green, Jody L
The New England Journal of Medicine, ISSN 0028-4793, 01/2015, Volume 372, Issue 3, pp. 241 - 248
The authors analyzed data from five national surveillance programs and report that rates of abuse and diversion of opioid medications increased during... 
DIVERSION | MEDICINE, GENERAL & INTERNAL | IMPACT | COLLEGE-STUDENTS | PRESCRIPTION | EXTENDED-RELEASE OXYCODONE | NONMEDICAL USE | Opioid-Related Disorders - epidemiology | United States - epidemiology | Drug Prescriptions - statistics & numerical data | Oxycodone - therapeutic use | Prescription Drug Diversion - trends | Drug Utilization - trends | Humans | Opioid-Related Disorders - mortality | Drug and Narcotic Control - legislation & jurisprudence | Product Surveillance, Postmarketing | Analgesics, Opioid - therapeutic use | Heroin Dependence - epidemiology | Drug abuse | United States | Mortality | Analysis | Opioids | Health aspects | Risk factors | Prescription drugs | Analgesics | Addiction | Narcotics | Tramadol | Oxycodone | Fentanyl | Morphine | Pharmaceutical industry | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Development and validation of an in vitroein vivo correlation (IVIVC) model for propranolol hydrochloride extended-release matrix formulations
by Cheng, Chinhwa and Wu, Pao-Chu and Lee, Hsin-Ya and Hsu, Kuang-Yang
Journal of Food and Drug Analysis, ISSN 1021-9498, 06/2014, Volume 22, Issue 2, pp. 257 - 263
The objective of this study was to develop an in vitroein vivo correlation (IVIVC) model for hydrophilic matrix extended-release (ER) propranolol dosage... 
Propranolol | Extended-release dosage | IVIVC
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Treatment of children and adolescents with attention deficit hyperactivity disorder and/or tourette’s disorder with clonidine extended release
by Joo, Sung Woo and Kim, Hyo-Won
Psychiatry Investigation, ISSN 1738-3684, 01/2018, Volume 15, Issue 1, pp. 90 - 93
We aimed to assess the effectiveness and safety of clonidine extended release (ER) treatment in Korean youth with ADHD and/or Tourette’s disorder. We... 
Clonidine extended release | Tourette’s disorder | 정신과학
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
by Silverman, Michael G and Ference, Brian A and Im, Kyungah and Wiviott, Stephen D and Giugliano, Robert P and Grundy, Scott M and Braunwald, Eugene and Sabatine, Marc S
JAMA, ISSN 0098-7484, 09/2016, Volume 316, Issue 12, pp. 1289 - 1297
IMPORTANCE: The comparative clinical benefit of nonstatin therapies that reduce low-density lipoprotein cholesterol (LDL-C) remains uncertain. OBJECTIVE: To... 
MEDICINE, GENERAL & INTERNAL | DENSITY-LIPOPROTEIN CHOLESTEROL | HIGH-DOSE ATORVASTATIN | MYOCARDIAL-INFARCTION | RANDOMIZED CONTROLLED-TRIAL | PLACEBO-CONTROLLED TRIAL | CORONARY-HEART-DISEASE | TYPE-2 DIABETES-MELLITUS | EXTENDED-RELEASE NIACIN | PRIMARY PREVENTION | HYPERTENSIVE PATIENTS | Up-Regulation | Stroke - prevention & control | Risk Reduction Behavior | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Receptors, LDL - metabolism | Cholesterol, LDL - drug effects | Male | Niacin - administration & dosage | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Hypolipidemic Agents - administration & dosage | Female | Myocardial Infarction - prevention & control | Receptors, LDL - drug effects | Usage | Therapeutics | Cholesterol, LDL | Research | Cardiovascular diseases | Homeopathy | Materia medica and therapeutics | Cardiovascular disease | Systematic review | Low density lipoprotein | Statins
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
20. Full Text Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013
by Yatham, Lakshmi N and Kennedy, Sidney H and Parikh, Sagar V and Schaffer, Ayal and Beaulieu, Serge and Alda, Martin and O'Donovan, Claire and MacQueen, Glenda and McIntyre, Roger S and Sharma, Verinder and Ravinan, Arun and Young, L. Trevor and Milev, Roumen and Bond, David J and Frey, Benicio N and Goldstein, Benjamin I and Lafer, Beny and Birmaher, Boris and Ha, Kyooseob and Nolen, Willem A and Berk, Michael
Bipolar Disorders, ISSN 1398-5647, 02/2013, Volume 15, Issue 1, pp. 1 - 44
Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, ODonovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey... 
treatment | guidelines | bipolar | depression | CANMAT | mania | Mania | Bipolar | Depression | Treatment | Guidelines | PALIPERIDONE EXTENDED-RELEASE | TREATMENT OPTIMIZATION PROGRAM | PSYCHIATRY | RANDOMIZED CLINICAL-TRIAL | PATIENTS RECEIVING LAMOTRIGINE | NEUROSCIENCES | CLINICAL NEUROLOGY | SEROTONIN REUPTAKE INHIBITORS | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | COGNITIVE-BEHAVIORAL THERAPY | PLACEBO-CONTROLLED TRIAL | LONG-TERM TREATMENT | POST-HOC ANALYSIS | Guidelines as Topic - standards | Canada | Humans | Anti-Anxiety Agents - therapeutic use | Bipolar Disorder - diagnosis | Bipolar Disorder - drug therapy | Bipolar Disorder - epidemiology | Bipolar Disorder - psychology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights